Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Cash from Financing Activities (2016 - 2025)

Healthcare Services (HCSG) has disclosed Cash from Financing Activities for 17 consecutive years, with -$19.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 24.63% to -$19.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$63.3 million, a 103.97% decrease, with the full-year FY2025 number at -$63.3 million, down 103.97% from a year prior.
  • Cash from Financing Activities was -$19.6 million for Q4 2025 at Healthcare Services, up from -$27.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $14.0 million in Q1 2024 to a low of -$31.5 million in Q4 2021.
  • A 5-year average of -$11.4 million and a median of -$14.2 million in 2021 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: soared 213.63% in 2023, then plummeted 710.57% in 2024.
  • Healthcare Services' Cash from Financing Activities stood at -$31.5 million in 2021, then surged by 49.33% to -$16.0 million in 2022, then tumbled by 56.97% to -$25.0 million in 2023, then fell by 3.85% to -$26.0 million in 2024, then increased by 24.63% to -$19.6 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Cash from Financing Activities are -$19.6 million (Q4 2025), -$27.3 million (Q3 2025), and -$7.7 million (Q2 2025).